Strong global surveillance by the WHO and CDC, combined with no evidence of a novel pathogen achieving sustained human-to-human transmission at scale, underpins the 88.5% market-implied probability against a new pandemic in 2026. Current confirmed outbreaks, including the Bundibugyo Ebola strain in central Africa (now a PHEIC with over 1,000 cases but geographically limited) and a small Andes hantavirus cluster on a cruise ship, remain regionally contained without pandemic indicators such as widespread community transmission or high basic reproduction numbers. Post-COVID immunity layers, enhanced monitoring networks, and historical patterns of infrequent global events further support trader consensus that thresholds for a new pandemic declaration are unlikely to be crossed before year-end.